China Unveils Measures to Boost Innovative Drug Development With Insurance Data Support
China’s National Healthcare Security Administration (NHSA) and National Health Commission (NHC) jointly released the “Several...
NHSA (prev. SMIA)
China Proposes Healthcare Security Law to Strengthen Medical Insurance System
China’s National Healthcare Security Administration (NHSA) last week released the “Healthcare Security Law (draft proposal)”,...
NHSA Emphasizes Management of Designated Medical Institutions for Healthcare Quality
The National Healthcare Security Administration (NHSA) this week released a notification emphasizing the importance of...
NHSA Implements Region-Based Pricing System for Medical Services
China’s National Healthcare Security Administration (NHSA) this week issued the “Notice on Optimizing Medical Service...
NHSA Strengthens Pharmaceutical Pricing and Procurement Credit Evaluation Mechanism
The National Healthcare Security Administration (NHSA) issued a notification this week to refine its credit...
NHSA Launches Intelligent Supervision Reform Pilot in Designated Medical Institutions
The National Healthcare Security Administration (NHSA) has released a notification to implement an intelligent supervision...
China’s Medical Insurance Payment Reform Achieves Nationwide Coverage, Faces Challenges Ahead
The first blue book on the reform of China’s medical insurance payment methods, titled “Report...
Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency
The Beijing Municipal Medical Insurance Bureau, in collaboration with seven other bureaus, has released the...
China’s NHSA Releases 2024 Healthcare Security Bulletin Highlighting Insurance Coverage and Reimbursement
China’s National Healthcare Security Administration (NHSA) has released its 2024 “Healthcare Security Development Statistical Bulletin.”...
China’s NHSA Issues Guidelines for Neurological Medical Services Pricing
China’s National Healthcare Security Administration (NHSA) has released the “Guidelines for the Pricing Project Initiation...
In-Depth Analysis of the National Healthcare Security Policy: A Guide to Key Reforms and Implications
The National Healthcare Security Administration (NHSA) has unveiled its 2025 priority action list, focusing on...
China’s Drug Procurement Under Scrutiny: Addressing Quality Concerns and Policy Reforms
An In – Depth Exploration of the Recent Survey on Bulk Drug Procurement in China...
In-Depth Analysis of NHSA’s DRG/DIP Payment Reforms: A Path to Streamlined Healthcare Management
Comprehensive Overhaul of Payment SystemsThe National Healthcare Security Administration (NHSA) has unveiled a series of...
NHSA Regulates DRG/DIP Payment Methods Under ‘1+3+N’ System
The National Healthcare Security Administration (NHSA) has released a set of regulations aimed at improving...
China’s NHSA and MoF Push for DRG/DIP Payment Reforms by 2025
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly released...
NHSA Targets Low-Volume Drugs in National Reimbursement List
The National Healthcare Security Administration (NHSA) in China has released a list of 131 drugs...
NHSA Outlines 2025 Work Plan and 2024 Medical Insurance Status
The National Healthcare Security Administration (NHSA) last week held a press conference, addressing questions regarding...
NHSA Seeks Expert Opinions on VBP Drug Quality and Efficacy
The National Healthcare Security Administration (NHSA) has released a letter titled “Letter on Requesting Assistance...
NHSA Pushes for Real-Time Settlement Reform in Basic Medical Insurance
The National Healthcare Security Administration (NHSA) has released a notification to promote the real-time settlement...
Suzhou Ribo and Boehringer Ingelheim Reach Pre-Clinical Milestone in NASH/MASH Partnership
China-based Suzhou Ribo Life Science Co., Ltd has announced the achievement of a first pre-clinical...